European Investment Bank

Royal Schiphol Group N.V. is the owner and operator of Amsterdam Airport Schiphol, the national airport of the Netherlands, as well as other airports including Rotterdam The Hague Airport and Lelystad Airport. The company manages and develops airport operations, providing essential services and facilities to airlines, travelers, handling agents, and logistics providers. It also grants concessions for various shops, restaurants, and entertainment options within the airport, while operating its own retail spaces and car parks. Additionally, Royal Schiphol Group develops and manages properties related to airport activities, offering various locations and rental agreements for businesses and logistics service providers. Established in 1958 and headquartered in Schiphol, the company plays a crucial role in aviation and transportation in the Netherlands and beyond.

Samotics is a Dutch technology company that specializes in improving the availability of industrial electric motors and rotating equipment through its AI-powered condition monitoring platform. The company leverages data from sensors and operational systems to identify early warnings of abnormal behavior, enabling targeted inspections and predictive maintenance. By analyzing this data, Samotics helps global industrial companies reduce energy waste and unplanned downtime, ultimately lowering operational costs and risks. Its customer base includes leading organizations such as Anglian Water, ArcelorMittal, and Nobian, reflecting its significant impact on the industrial sector.

NXP Semiconductors N.V. is a prominent supplier of high-performance mixed-signal semiconductor products, headquartered in Eindhoven, the Netherlands. Founded in 2006, the company offers a diverse product portfolio that includes microcontrollers, application processors, communication processors, and various wireless connectivity solutions such as Bluetooth, Wi-Fi, and Near Field Communications. NXP's technology is integral to multiple applications across automotive, industrial, Internet of Things, mobile, and communication infrastructure sectors. The company has established a significant presence in the automotive market, providing essential components for powertrains, infotainment systems, and safety systems. Additionally, NXP maintains operations in over 25 countries and has formed strategic partnerships, including collaboration with Amazon Web Services to enhance connected vehicle solutions.

Nyxoah focuses on developing and commercializing solutions to treat sleep-disordered breathing conditions. Its primary product is the Genio system, a CE-Mark validated bilateral neuro-stimulation therapy for moderate to severe obstructive sleep apnea.

Intrinsic ID B.V. is a digital authentication company specializing in security solutions for the Internet of Things (IoT) and embedded applications. Founded in 2008 and based in Eindhoven, the Netherlands, with operations in Korea, the company has developed the SRAM Physical Unclonable Function (SRAM PUF) technology that utilizes manufacturing variations in semiconductors to generate unique IDs and cryptographic keys. Its product offerings include Broadkey, Citadel, Quiddicard, and Quiddikey, which facilitate secure key management, key provisioning, and anti-counterfeiting measures. Intrinsic ID's solutions are employed to enhance the security of payment systems, ensure secure connectivity, authenticate sensors, and protect sensitive military and government data.

Founded in 1720, ABN AMRO Bank is a leading Dutch bank offering comprehensive financial services to retail, private, and corporate clients. It operates through Retail Banking, Commercial Banking, Private Banking, and Corporate & Institutional Banking segments, serving clients both domestically and internationally.

ExeVir Bio BV is a Belgian biotechnology company founded in 2020 and headquartered in Zwijnaarde. The company specializes in developing single-domain antibody-based therapies aimed at preventing viral infections. Utilizing a llama-derived antibody technology platform, ExeVir Bio focuses on creating robust antiviral treatments, particularly targeting coronaviruses. One of its key products, VHH72-FC, binds to a conserved region of the SARS-CoV-2 spike protein, which is crucial for the virus's entry into human cells. The company has established a rapid response platform for antivirals, allowing for a quick adaptation to emerging health threats through a streamlined process for generating drug candidates. Their protein-based therapeutics are designed to be stable, cost-effective, and accessible on a global scale, addressing significant public health challenges posed by viral infections.

Founded in 2016 and headquartered in Leiden, Netherlands, LeydenJar Technologies specializes in enhancing lithium-ion battery performance by replacing traditional graphite anodes with nanoporous, pure silicon anodes. This innovation results in batteries that are cheaper (-20%), greener (-85% CO2 footprint), and have higher energy density (+70%).

Energiefonds Overijssel is a venture capital firm established in 2012 and located in Zwolle, Netherlands. The company is dedicated to supporting the energy transition by providing financial contributions to initiatives and businesses that focus on energy savings or the generation of energy from renewable sources. Backed by the government, Energiefonds Overijssel prioritizes investments in renewable energy and clean energy technology, aiming to foster sustainable practices and innovation within the energy sector.

Airborne International is engaged in engineering, manufacturing, and supplying high-end composites structures for industries such as aerospace, defense, marine, high-end bicycles, and formula-one cars. It offers composites structures maintenance and repair services, including inspection and damage assessment, sealing and painting, and balancing. The company was founded in 1995 and is based in The Hague, the Netherlands.

DPG Media Group is a media company based in Antwerp, Belgium, specializing in the publication of newspapers, journals, and magazines. It provides a diverse array of news coverage, including entertainment, sports, politics, and market-related stories. In addition to its publishing activities, DPG Media offers advertising services to its clients, catering to a wide audience across Belgium. The company's content encompasses social, scientific, economic, and commercial topics, ensuring a comprehensive approach to media and information dissemination.

miDiagnostics is a Belgian company focused on creating innovative testing solutions that allow individuals to perform blood analyses independently. The company is developing a novel chip-based technology that enables the rapid detection of various biomarkers from minimal blood samples, such as those obtained from a finger prick. This technology integrates a nanofluidic processor with a compact reader, facilitating the measurement of cells, proteins, nucleic acids, and small molecules. By providing disposable tests that are easy to use and offer built-in connectivity, miDiagnostics aims to enhance diagnostic capabilities for both patients and clinicians, making lab-quality testing accessible anytime and anywhere.

Xeltis is a clinical-stage medical device company developing bio-absorbable heart valves and blood vessels. Its RestoreX technology enables the body's natural healing system to create functional tissue within its devices, forming new valves or vessels over time. Headquartered in Zurich, Switzerland, with R&D and manufacturing facilities in Eindhoven, Netherlands, Xeltis aims to transform cardiovascular care.

Bone Therapeutics, a Belgian biotechnology company established in 2006, specializes in developing innovative cell therapy products to treat orthopedic conditions and bone diseases. Its flagship product, ALLOB, is an allogeneic cell therapy currently in Phase II trials for delayed-union fractures and spinal fusion.

AM Pharma B.V. is a biopharmaceutical company based in Bunnik, the Netherlands, focused on developing and commercializing novel therapeutics for inflammatory and infectious diseases. Established in 2000, the company specializes in pre-clinical and clinical development using endogenous proteins and peptides derived from the human body. Its key products include alkaline phosphatase, aimed at treating acute kidney injury and ulcerative colitis, and the immune response amplifying peptide hLF1-11, which targets drug-resistant hospital-acquired infections. AM Pharma is committed to providing innovative therapies that enhance patient quality of life by addressing critical medical needs.

Founded in 2012, Azimo is a London-based digital money transfer network that enables users to send money internationally via its mobile apps or web platform. It offers fast, secure, and low-cost transfers to bank accounts or over 270,000 cash pick-up points worldwide.

ISA Pharmaceuticals B.V. is a clinical-stage immunotherapy company headquartered in Leiden, the Netherlands, that specializes in developing synthetic long peptide-based therapies. Founded in 2004, the company focuses on addressing unmet medical needs in cancer and persistent viral infections. Utilizing its proprietary Synthetic Long Peptide (SLP®) platform and AMPLIVANT® technology, ISA Pharmaceuticals designs fully synthetic immunotherapeutics aimed at activating the body’s immune response to combat disease. These innovative therapies can be administered alone or in combination with existing treatments, enhancing the likelihood of successful patient outcomes.

MotorK is a SaaS provider specializing in digital sales and marketing solutions for the automotive retail industry across EMEA. With over 400 employees and offices in eight countries, MotorK empowers car manufacturers and dealers to enhance customer experience through integrated digital products and services.

October is a pan-European lending platform that aims to empower businesses by simplifying access to funding. Founded in France in 2014 under the name Lendix, the company emerged following regulatory changes that disrupted traditional banking practices. With offices in France, Spain, Italy, and the Netherlands, October operates an online marketplace that connects private investors with enterprises of various sizes. This platform allows investors to finance businesses directly, offering fully disclosed terms and facilitating a streamlined investment process. Institutional lenders complement individual contributions, ensuring borrowers benefit from high success rates and quick processing times. October's mission is to democratize finance, providing a secure and efficient way for individuals to invest in the real economy.

iZettle AB is a financial technology company based in Stockholm, Sweden, that specializes in mobile payment services and applications designed for small businesses and entrepreneurs. Founded in 2010, it revolutionized the industry with the introduction of the first mini chip card reader, enabling businesses to accept card payments through smartphones and tablets. iZettle offers a range of products, including the iZettle Card Reader Lite and an application compatible with iOS and Android devices, which facilitate payment processing, business management, sales analytics, and customer engagement. The company serves a diverse clientele across several countries, including Sweden, Norway, Denmark, Finland, the United Kingdom, Germany, Spain, Mexico, the Netherlands, and Brazil. As of 2018, iZettle operates as a subsidiary of PayPal Holdings, Inc.